Predicting amyloid PET and tau PET stages with plasma biomarkers

Staging the severity of Alzheimer’s disease pathology using biomarkers is useful for therapeutic trials and clinical prognosis. Disease staging with amyloid and tau PET has face validity; however, this would be more practical with plasma biomarkers. Our objectives were, first, to examine approaches...

Descripción completa

Detalles Bibliográficos
Autores principales: Jack, Clifford R, Wiste, Heather J, Algeciras-Schimnich, Alicia, Figdore, Dan J, Schwarz, Christopher G, Lowe, Val J, Ramanan, Vijay K, Vemuri, Prashanthi, Mielke, Michelle M, Knopman, David S, Graff-Radford, Jonathan, Boeve, Bradley F, Kantarci, Kejal, Cogswell, Petrice M, Senjem, Matthew L, Gunter, Jeffrey L, Therneau, Terry M, Petersen, Ronald C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151195/
https://www.ncbi.nlm.nih.gov/pubmed/36789483
http://dx.doi.org/10.1093/brain/awad042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151195/
https://www.ncbi.nlm.nih.gov/pubmed/36789483
http://dx.doi.org/10.1093/brain/awad042

Ejemplares similares